REATA PHARMACEUTICALS
LIVE

Serial Number

90706652

Owner

Reata Pharmaceuticals, Inc.

Attorney

Andrea K. Shannon

Filing Date

May 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

REATA PHARMACEUTICALS Trademark

Serial Number: 90706652 • Registration: 6875316

REATA PHARMACEUTICALS is a trademark filed by Reata Pharmaceuticals, Inc. on May 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Reata Pharmaceuticals, Inc. (24 trademarks)

2801 Gateway Drive, Suite 150
Irving, TX 75063

Entity Type: 03

Trademark Details

Filing Date

May 12, 2021

Registration Date

October 18, 2022

Published for Opposition

August 2, 2022

Goods & Services

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and for use in oncology, ophthalmology, and the prevention and treatment of gastrointestinal diseases, diseases and disorders of the immune system including autoimmune diseases, skin diseases, and kidney diseases

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 24, 2023 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 18, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2022 CNSA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 26, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 12, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2021 NWOS
NEW APPLICATION ENTERED
May 15, 2021 NWAP